Martijn Cox

Founder at Xeltis AG

Consumer Services

Health Technology

Technology Services

Profile

Martijn Cox is the founder of Xeltis BV, founded in 2007, and Xeltis AG, founded in 2006, where he holds the title of Chief Technology Officer.
He has a graduate and doctorate degree from TiasNimbas Business School BV.

Martijn Cox active positions

Companies	Position	Start
Xeltis AG Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.	Founder	31/12/2005
Xeltis BV Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands.	Founder	19/11/2007

All active positions of Martijn Cox

Training of Martijn Cox

TiasNimbas Business School BV

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martijn Cox's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Xeltis AG Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland.	Health Technology
Xeltis BV Xeltis BV Packaged SoftwareTechnology Services Xeltis BV develops self-growing heart valves out of patients tissue. The company was headquartered in Glasgow, the United Kingdom. The company was founded on November 20, 2007 by Mirjam Rubbens and Martijn Cox and is headquartered in Eindhoven, the Netherlands.	Technology Services